RESISTANCE TO PARVOVIRUS B19 INFECTION DUE TO LACK OF VIRUS RECEPTOR (ERYTHROCYTE P-ANTIGEN)

被引:220
作者
BROWN, KE
HIBBS, JR
GALLINELLA, G
ANDERSON, SM
LEHMAN, ED
MCCARTHY, P
YOUNG, NS
机构
[1] MT EATON CLIN,MT EATON,OH
[2] AMER RED CROSS,CLEVELAND,OH
关键词
D O I
10.1056/NEJM199404283301704
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The presence of aspecific cellular receptor is thought to be necessary for susceptibility to viral infection. The erythrocyte P antigen is the cellular receptor for parvovirus B19. We hypothesized that the rare persons with the p phenotype, whose erythrocytes do not have this receptor, would be naturally resistant to B19 infection, which causes erythema infectiosum. Methods. Blood samples were collected from two populations in cross-sectional studies. We determined the P antigen phenotype of the red cells and tested plasma for anti-B19-specific antibodies. Bone marrow from donors of known P antigen phenotype was inoculated with parvovirus B19. Infectivity was measured by assays of erythroid progenitor cells, dot blot analysis, and in situ hybridization for B19 DNA, and an immunofluorescence assay for viral-capsid proteins. Results. Of the 17 subjects with the p red-cell phenotype, who did not have P antigen on their erythrocytes, none (0 of 11 and 0 of 6) had serologic evidence of previous parvovirus B19 infection. In contrast, the seropositivity rates in the two control groups were 71 percent (53 of 75, P<0.001) and 47 percent (32 of 68, P = 0.03). In vitro, bone marrow from donors with the p phenotype maintained normal erythropoiesis despite very high concentrations of virus, with no evidence of infection of erythroid progenitor cells by parvovirus B19. Conclusions. People who do not have P antigen, which is the cellular receptor for parvovirus B19, are naturally resistant to infection with this pathogen.
引用
收藏
页码:1192 / 1196
页数:5
相关论文
共 29 条
  • [1] AGRE PC, 1992, PROTEIN BLOOD GROUP, pR11
  • [2] ROLE OF PARVOVIRUS B19 IN HUMAN-DISEASE
    ANDERSON, LJ
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (08) : 711 - 718
  • [3] ANDERSON MJ, 1983, LANCET, V1, P1378
  • [4] ERYTHROCYTE-P ANTIGEN - CELLULAR RECEPTOR FOR B19 PARVOVIRUS
    BROWN, KE
    ANDERSON, SM
    YOUNG, NS
    [J]. SCIENCE, 1993, 262 (5130) : 114 - 117
  • [5] WHAT THREAT IS HUMAN PARVOVIRUS-B19 TO THE FETUS - A REVIEW
    BROWN, KE
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (07): : 764 - 767
  • [6] INVITRO-PROPAGATION OF PARVOVIRUS B19 IN PRIMARY FETAL LIVER CULTURE
    BROWN, KE
    MORI, J
    COHEN, BJ
    FIELD, AM
    [J]. JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 741 - 745
  • [7] DIAGNOSTIC ASSAYS WITH MONOCLONAL-ANTIBODIES FOR THE HUMAN-SERUM PARVOVIRUS-LIKE VIRUS (SPLV)
    COHEN, BJ
    MORTIMER, PP
    PEREIRA, MS
    [J]. JOURNAL OF HYGIENE, 1983, 91 (01) : 113 - &
  • [8] RECENT PROGRESS IN THE UNDERSTANDING OF THE ROLE OF BACTERIAL ADHESION IN THE PATHOGENESIS OF URINARY-TRACT INFECTION
    EDEN, CS
    HAGBERG, L
    LEFFLER, H
    LOMBERG, H
    [J]. INFECTION, 1982, 10 (05) : 327 - 332
  • [9] PERSISTENT B19 PARVOVIRUS INFECTION IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) - A TREATABLE CAUSE OF ANEMIA IN AIDS
    FRICKHOFEN, N
    ABKOWITZ, JL
    SAFFORD, M
    BERRY, JM
    ANTUNEZDEMAYOLO, J
    ASTROW, A
    COHEN, R
    HALPERIN, I
    KING, L
    MINTZER, D
    COHEN, B
    YOUNG, NS
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 113 (12) : 926 - 933
  • [10] INSITU DETECTION OF B19 DNA IN BONE-MARROW OF IMMUNODEFICIENT PATIENTS USING A DIGOXIGENIN-LABELED PROBE
    GENTILOMI, G
    ZERBINI, M
    MUSIANI, M
    GALLINELLA, G
    GIBELLINI, D
    VENTUROLI, S
    RE, MC
    PILERI, S
    FINELLI, C
    LAPLACA, M
    [J]. MOLECULAR AND CELLULAR PROBES, 1993, 7 (01) : 19 - 24